[1] Inst Gustave Roussy, Villejuif, France
[2] INSERM, U848, Villejuif, France
[3] Univ Paris 11, Fac Med, Le Kremlin Bicetre, France
[4] Unite Genom Fonct & Bioinformat, Villejuif, France
[5] Genom Platform, Villejuif, France
[6] Georges Francois Leclerc Ctr, Dept Med Oncol, Dijon, France
[7] Univ Burgundy, CRI 866, Avenir Team, INSERM, Dijon, France
[8] INSERM, U1015, Villejuif, France
[9] Dept Biol & Pathol Med, Villejuif, France
[10] Univ Roma Tre, Dipartimento Biol, Rome, Italy
[11] Natl Inst Infect Dis L Spallanzani, Rome, Italy
[12] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy
[13] Univ Oviedo, Inst Univ Oncol IUOPA, Fac Med, Dept Biol Func, Oviedo, Spain
[14] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic, Australia
[15] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia
[16] Monash Univ, Dept Immunol, Prahran, Vic, Australia
[17] Austrian Acad Sci IMBA, Inst Mol Biotechnol, Vienna, Austria
[18] Antoine Beclere Hosp, AP HP, Dept Minimal Invas Surg, Clamart, France
[19] INSERM, U972, F-94275 Le Kremlin Bicetre, France
[20] Inst Mol Biosci, Graz, Austria
[21] Univ Oviedo, IUOPA, Fac Med, Dept Bioquim & Biol Mol, Oviedo, Spain
[22] Ctr Clin Invest Biotherapies Canc CICBT 507, Villejuif, France
[23] Ctr Rech Cordeliers, Paris, France
[24] Hop Europeen Georges Pompidou, AP HP, Paris, France
[25] Univ Paris 05, Paris, France